Carregant...

Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors

Cancer immunotherapy is a promising treatment strategy that aims to strengthen immune responses against cancer. However, the low immunogenicity of tumor cells and inhibition of effector T cells in the tumor immunosuppressive microenvironment remain two major challenges. Immunogenic cell death (ICD)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Nanomedicine
Autors principals: Qi, Jing, Jin, Feiyang, Xu, Xiaoling, Du, Yongzhong
Format: Artigo
Idioma:Inglês
Publicat: Dove 2021
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7910111/
https://ncbi.nlm.nih.gov/pubmed/33654395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S285999
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!